AKT1 and rhizomelic chondrodysplasia punctata: Exacerbated GSK‐3β activity is also present in other peroxisomal diseases, like rhizomelic chondrodysplasia punctata, in which plasmalogen deficiency leads to AKT inactivation and GSK‐3β activation (da Silva et al, 2014).